| Melissa R Hunt, FNP-C | |
|
1530 N 7th St, Terre Haute, IN 47807-1057 | |
| (812) 238-7878 | |
| Not Available |
| Full Name | Melissa R Hunt |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 1530 N 7th St, Terre Haute, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275190845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 28207734A (Indiana) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 71009433A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Proactive Clinical Partners | 8527315852 | 32 |
| Proactive Clinical Partners - Aco | 5890154884 | 21 |
News Archive
The Leipzig Helmholtz Center for Environmental Research has gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children, how exposure to tobacco smoke affects the development of human immune system on molecular level.
Premier Insurance Management Services Inc. (PIMS), a wholly owned subsidiary of the Premier healthcare alliance, has introduced a new Clinical Risk Management (CRM) assessment program designed to evaluate performance and collaboration across the risk management, safety and quality functions in hospitals and healthcare systems.
SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing. SutroVax is developing vaccines for infectious disease targets, with an initial emphasis on best-in-class conjugate vaccines, using an exclusive license to Sutro Biopharma's Xpress CF and Xpress CF+ platforms for cell free protein synthesis and site-specific conjugation respectively.
In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide
› Verified 5 days ago
| Entity Name | Arnett Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164490843 PECOS PAC ID: 0749184380 Enrollment ID: O20031125000119 |
News Archive
The Leipzig Helmholtz Center for Environmental Research has gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children, how exposure to tobacco smoke affects the development of human immune system on molecular level.
Premier Insurance Management Services Inc. (PIMS), a wholly owned subsidiary of the Premier healthcare alliance, has introduced a new Clinical Risk Management (CRM) assessment program designed to evaluate performance and collaboration across the risk management, safety and quality functions in hospitals and healthcare systems.
SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing. SutroVax is developing vaccines for infectious disease targets, with an initial emphasis on best-in-class conjugate vaccines, using an exclusive license to Sutro Biopharma's Xpress CF and Xpress CF+ platforms for cell free protein synthesis and site-specific conjugation respectively.
In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide
› Verified 5 days ago
| Entity Name | Union Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013965573 PECOS PAC ID: 8426943614 Enrollment ID: O20040519000807 |
News Archive
The Leipzig Helmholtz Center for Environmental Research has gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children, how exposure to tobacco smoke affects the development of human immune system on molecular level.
Premier Insurance Management Services Inc. (PIMS), a wholly owned subsidiary of the Premier healthcare alliance, has introduced a new Clinical Risk Management (CRM) assessment program designed to evaluate performance and collaboration across the risk management, safety and quality functions in hospitals and healthcare systems.
SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing. SutroVax is developing vaccines for infectious disease targets, with an initial emphasis on best-in-class conjugate vaccines, using an exclusive license to Sutro Biopharma's Xpress CF and Xpress CF+ platforms for cell free protein synthesis and site-specific conjugation respectively.
In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide
› Verified 5 days ago
| Entity Name | Proactive Clinical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366934242 PECOS PAC ID: 8527315852 Enrollment ID: O20180718001740 |
News Archive
The Leipzig Helmholtz Center for Environmental Research has gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children, how exposure to tobacco smoke affects the development of human immune system on molecular level.
Premier Insurance Management Services Inc. (PIMS), a wholly owned subsidiary of the Premier healthcare alliance, has introduced a new Clinical Risk Management (CRM) assessment program designed to evaluate performance and collaboration across the risk management, safety and quality functions in hospitals and healthcare systems.
SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing. SutroVax is developing vaccines for infectious disease targets, with an initial emphasis on best-in-class conjugate vaccines, using an exclusive license to Sutro Biopharma's Xpress CF and Xpress CF+ platforms for cell free protein synthesis and site-specific conjugation respectively.
In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide
› Verified 5 days ago
| Entity Name | Proactive Clinical Partners - Aco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821709031 PECOS PAC ID: 5890154884 Enrollment ID: O20230710000733 |
News Archive
The Leipzig Helmholtz Center for Environmental Research has gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children, how exposure to tobacco smoke affects the development of human immune system on molecular level.
Premier Insurance Management Services Inc. (PIMS), a wholly owned subsidiary of the Premier healthcare alliance, has introduced a new Clinical Risk Management (CRM) assessment program designed to evaluate performance and collaboration across the risk management, safety and quality functions in hospitals and healthcare systems.
SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing. SutroVax is developing vaccines for infectious disease targets, with an initial emphasis on best-in-class conjugate vaccines, using an exclusive license to Sutro Biopharma's Xpress CF and Xpress CF+ platforms for cell free protein synthesis and site-specific conjugation respectively.
In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa R Hunt, FNP-C 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Melissa R Hunt, FNP-C 1530 N 7th St, Terre Haute, IN 47807-1057 Ph: (812) 238-7878 |
News Archive
The Leipzig Helmholtz Center for Environmental Research has gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children, how exposure to tobacco smoke affects the development of human immune system on molecular level.
Premier Insurance Management Services Inc. (PIMS), a wholly owned subsidiary of the Premier healthcare alliance, has introduced a new Clinical Risk Management (CRM) assessment program designed to evaluate performance and collaboration across the risk management, safety and quality functions in hospitals and healthcare systems.
SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing. SutroVax is developing vaccines for infectious disease targets, with an initial emphasis on best-in-class conjugate vaccines, using an exclusive license to Sutro Biopharma's Xpress CF and Xpress CF+ platforms for cell free protein synthesis and site-specific conjugation respectively.
In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide
› Verified 5 days ago